title: Serological Monitoring Is Key To Sustain Progress of the Maternal and Neonatal Tetanus Elimination Initiative.
abstract: In this issue of Clinical and Vaccine Immunology, Scobie and colleagues (H. M. Scobie et al., Clin Vaccine Immunol 23:546-554, 2016, http://dx.doi.org/10.1128/CVI.00052-16) report a nationwide serosurvey of tetanus immunity in >2,000 Cambodian women of child-bearing age to monitor progress toward maternal and neonatal tetanus elimination. This commentary discusses vaccines as interventions for disease control, elimination, and eradication and emphasizes the importance of the tools needed to monitor the effectiveness of initiatives that deliver the vaccines programmatically.
authors.affiliation: Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA mlevine@medicine.umaryland.edu.
authors.forename: Myron M
authors.initials: MM
authors.lastname: Levine
authors.affiliation: Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
authors.forename: Marcela F
authors.initials: MF
authors.lastname: Pasetti
mesh_terms: D006801:Humans; D018805:Sepsis; D013742:Tetanus / Q000517:prevention & control*; D013745:Tetanus Toxoid; D014611:Vaccination
chemical_list: D013745:Tetanus Toxoid